A Study of GW856553X For the Treatment of Depression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00569062
Recruitment Status : Terminated (Negative data from a GSK PoC study in RA combined with evidence of greater sensitivity of toll-like receptor pathways to p38 inhibition.)
First Posted : December 6, 2007
Last Update Posted : July 18, 2017
Information provided by (Responsible Party):

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 25, 2008
  Actual Study Completion Date : June 25, 2008
  Certification/Extension First Submitted : July 22, 2009

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 August 4, 2017
February 22, 2018
2 March 26, 2018
(Canceled - Date Unknown)
March 30, 2018